Kegelman et al. showed that syntenin could phosphorylate STAT3, and the resulting activation enhanced the expression of the EMT-related markers MMP2 and MMP9 and promoted the migration of prostate cancer cells [31]. This evidence concerns the gene MMP9 and prostate cancer.